Tachycardia (Tachyarrhythmias)

Subscribe to Selected New Research on Tachycardia

9836 relevant articles (639 outcomes, 718 trials/studies) found for this Disease

Description: Abnormally rapid heartbeat, usually with a HEART RATE above 100 beats per minute for adults. Tachycardia accompanied by disturbance in the cardiac depolarization (cardiac arrhythmia) is called tachyarrhythmia.

Also Known As:

Tachyarrhythmias; Tachycardias; Tachyarrhythmia

Relationship Network

Disease Context: Research Results

Cardiovascular Diseases: 20552

Heart Diseases: 13044

Cardiac Arrhythmias: 9023

Tachycardia: 9836

Ventricular Tachycardia: 5114

Supraventricular Tachycardia: 1467

Paroxysmal Tachycardia: 195

Reciprocating Tachycardia: 105

Signs and Symptoms Pathological Conditions

Pathologic Processes: 2442

Cardiac Arrhythmias: 9023

Tachycardia: 9836

Ventricular Tachycardia: 5114

Supraventricular Tachycardia: 1467

Paroxysmal Tachycardia: 195

Reciprocating Tachycardia: 105

Related Diseases

1.	Hypertension (High Blood Pressure)
2.	Atrial Fibrillation
3.	Tachycardia (Tachyarrhythmias)
4.	Ventricular Tachycardia
5.	Myocardial Infarction

Experts

1.	Nattel, Stanley: 8 articles (10/2008 - 05/2002)
2.	Aizawa, Yoshifusa: 8 articles (09/2007 - 08/2002)
3.	Chinushi, Masaomi: 8 articles (09/2007 - 08/2002)
4.	Komura, Satoru: 7 articles (09/2007 - 03/2003)
5.	Washizuka, Takashi: 7 articles (01/2007 - 08/2002)
6.	Furushima, Hiroshi: 6 articles (09/2007 - 04/2005)
7.	Moss, Arthur J: 5 articles (06/2008 - 01/2004)
8.	Wolpert, Christian: 5 articles (05/2008 - 08/2003)
9.	Kurita, Takashi: 5 articles (01/2008 - 04/2002)
10.	Kamakura, Shiro: 5 articles (01/2008 - 04/2002)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Tachycardia:

1.	Amiodarone (Amiodarona)FDA LinkGeneric 04/01/2001 - "Antiarrhythmic agents with amiodarone-like electrophysiological actions, but with a more favorable pharmacokinetic profile than amiodarone would be extremely useful for the treatment of many tachyarrhythmias. " 12/01/1997 - "Amiodarone is highly effective in suppressing ventricular and supraventricular tachyarrhythmias. " 04/01/1996 - "Intravenous amiodarone is safe and effective in most young patients with critical tachyarrhythmia. " 12/01/1995 - "BACKGROUND: After several days of loading, oral amiodarone, a class III antiarrhythmic, is highly effective in controlling ventricular tachyarrhythmias; however, the delay in onset of activity is not acceptable in patients with immediately life-threatening arrhythmias. " 01/01/1992 - "In the present case, as in the others reported in the literature, the drug of choice seems to be Amiodarone which appears to be the most effective in preventing tachyarrhythmias caused by swallowing." Order ALL the reference details at left...
2.	Sotalol (Sotalol Hydrochloride)FDA LinkGeneric 09/01/1987 - "In preliminary studies sotalol appeared effective in most forms of supraventricular tachyarrhythmias with its effects being similar to those of other beta-blockers. " 07/01/1987 - "In contrast, sotalol was highly effective in preventing the induction of reentrant ventricular tachyarrhythmias. " 12/01/2001 - "CONCLUSION: Sotalol, being an effective and safe drug particularly in children, is a good therapeutic alternative for the preventive treatment of childhood tachyarrhythmias." 01/01/1999 - "OBJECTIVES: This study evaluates the clinical efficacy of d,l-sotalol in patients with sustained ventricular tachyarrhythmias. " 11/01/1993 - "Acute and chronic antiarrhythmic efficacy of d-sotalol in patients with sustained ventricular tachyarrhythmias." Order ALL the reference details at left...
3.	Verapamil (Calan)FDA LinkGeneric 01/01/1986 - "Intravenous verapamil is highly effective in the termination of paroxysmal reciprocating atrioventricular tachycardia, whether associated with preexcitation or involving the atrioventricular node alone. " 03/01/1985 - "In AV nodal re-entrant tachycardia, verapamil was the most effective for termination. " 09/15/2005 - "The main results showed that treatment with verapamil was associated with a trend towards an higher percentage of atrial pacing in comparison with control (mean value+/-S.D.=63.2+/-29.9% vs. 57.3+/-30.6%, median value 53% vs. 49%, P value at Wilcoxon signed rank test=0.069), but without any significant reduction in atrial tachyarrhythmia burden (4.5+/-11.8 vs. 3.3+/-9.1%) or total hours spent in atrial tachyarrhythmia (65+/-161 vs. 48+/-131 h). " 02/01/2001 - "RESULTS: In electrophysiologic studies, intravenously administered verapamil was effective for the termination of tachycardia in all six patients who received this treatment and for the prevention of tachycardia in four of five patients. " 03/15/1989 - "A second IV administration of verapamil was effective in reversal of the atrial tachycardia, and a tapering dosage of verapamil, PO, was used to maintain normal sinus rhythm." Order ALL the reference details at left...
4.	Anti-Arrhythmia AgentsIBA 06/01/1987 - "It can be administered safely to patients with sustained ventricular tachyarrhythmias and is as effective as approved antiarrhythmic drugs when assessed by electropharmacologic testing." 09/01/1993 - "Many new antiarrhythmic drugs effective in supraventricular tachyarrhythmia are now available. " 07/01/2001 - "TWA may also be a useful marker for evaluating the efficacy of antiarrhythmic drugs for ventricular tachyarrhythmias." 01/01/1993 - "In principle, all antiarrhythmic drugs (classes 1-3) are useful in the treatment of ventricular tachyarrhythmias. " 01/01/2007 - "In 44 patients (3 women and 41 men, mean age 54 +/- 11 years) with malignant ventricular tachyarrhythmias (MVT) we assessed dependence of results of testing of antiarrhythmic drugs and efficacy of their long term use for prevention of recurrences of MVT on topography of derangement of local left ventricular (LV) contractility. " Order ALL the reference details at left...
5.	Flecainide (Tambocor)FDA LinkGeneric 01/01/1988 - "This experience demonstrates that flecainide is highly effective in refractory atrial tachyarrhythmias. " 11/01/1985 - "Flecainide acetate is a recently introduced, class 1 antiarrhythmic agent that is highly effective in the treatment of ventricular and atrioventricular/nodal reentrant tachycardias. " 04/01/1990 - "Two infants with chaotic atrial tachycardia diagnosed at birth and at 11 weeks of life, were treated successfully with oral flecainide. " 02/01/1991 - "CONCLUSIONS: Oral flecainide therapy was effective in 33 of 63 patients who had tachycardia and an extranodal accessory connection. " 02/01/1990 - "It is suggested that flecainide might be effective in the treatment of atrial tachyarrhythmias." Order ALL the reference details at left...
6.	Propafenone (Rythmol)FDA LinkGeneric 01/01/1995 - "Propafenone is a potent antiarrhythmic agent effective in either supraventricular or ventricular tachyarrhythmias. " 04/01/1990 - "Seven of the 13 children (53.8%) with ventricular ectopics, all three children with paroxysmal re-entry atrioventricular tachycardia, and two of the three children with paroxysmal atrial tachycardia were treated successfully with propafenone. " 07/01/1991 - "Acute and long-term efficacy of propafenone in patients with sustained ventricular tachyarrhythmias: assessment with programmed ventricular stimulation." 08/01/1995 - "Although propafenone is effective in the acute management of junctional reentrant tachycardias, the availability of safer drugs precludes its routine use for these arrhythmias. " 09/15/1991 - "Propafenone was partially or completely effective in 3 of 4 patients with chaotic atrial tachycardia. " Order ALL the reference details at left...
7.	Adenosine FDA LinkGeneric 05/30/1999 - "It is emphasized that intravenous adenosine is highly effective in terminating sinus node, atrioventricular (AV) nodal and AV-reciprocating reentrant tachycardias. " 10/01/1999 - "However, for wide complex tachyarrhythmias, the diagnostic accuracy of the housestaff group significantly improved with the use of adenosine (pre = 54%, post = 70%, p < 0.01), while the attending physician group had no significant improvement (pre = 61%, post = 71%, p = NS). " 03/01/2001 - "PURPOSE: The antiarrhythmic efficacy of adenosine during states of AV-nodal reentrant tachycardias is well known and clinically established. " 08/01/1998 - "Adenosine is an antiarrhythmic substance particularly effective in catecholamine-dependent tachycardias. " 08/15/1994 - "Effects of intravenous adenosine in patients with preexcited junctional tachycardias: therapeutic efficacy and incidence of proarrhythmic events." Order ALL the reference details at left...
8.	Propranolol (Inderal)FDA LinkGeneric 06/01/1981 - "In conclusion, low-dose propranolol is very effective in preventing supraventricular tachyarrhythmia following aorta-coronary bypass in patients receiving beta blockers preoperatively. " 09/01/2009 - "CONCLUSIONS: Low-dose oral propranolol significantly attenuated tachycardia and improved symptoms in POTS. " 09/01/2009 - "Although the high dose elicited a greater decrease than the low dose in standing heart rate (P<0.001) and orthostatic tachycardia (P<0.001), the improvement in symptoms at 2 hours was greater with low-dose propranolol (-6 versus -2 arbitrary units; P=0.041). " 12/01/1989 - "The efficacy of intravenous propranolol for suppression of inducibility of sustained ventricular tachyarrhythmias (VT) was studied in 24 patients who had failed greater than or equal to 1 membrane-active antiarrhythmic drug (mean 2.2 +/- 1.2 drugs/patient). " 08/01/1982 - "Efficacy of low-dose propranolol in preventing postoperative supraventricular tachyarrhythmias: a prospective, randomized study." Order ALL the reference details at left...
9.	esmolol (Brevibloc)FDA LinkGeneric 02/01/1994 - "Esmolol, an ultrashort-acting beta-adrenergic blocking agent, has been reported in western published reports to have good results and few side effects in the treatment of supraventricular tachyarrhythmia. " 03/01/1991 - "A double-blind, randomised study was conducted to examine the efficacy of a single bolus dose of esmolol in treating surgically-induced tachycardia. " 07/01/1990 - "A randomized, double-blind, parallel, placebo-controlled study was conducted to determine the safety and efficacy of intravenous (IV) bolus administration of esmolol in treating intraoperative tachycardia in patients undergoing noncardiac general surgery. " 08/01/1988 - "This study supports previous observations concerning the safety and efficacy of esmolol in the treatment of supraventricular tachyarrhythmias. " 08/01/1988 - "Efficacy of esmolol in the treatment and transfer of patients with supraventricular tachyarrhythmias to alternate oral antiarrhythmic agents." Order ALL the reference details at left...
10.	Adenosine Triphosphate (ATP)IBA 07/01/1998 - "We consider that i.v. ATP administration in regular tachyarrhythmias in children is very useful for the proper diagnosis of the types with wide QRS complexes and/or when the P wave did not appear on the ECG, and also for the treatment, because ATP has a high effectiveness and an excellent tolerance." 04/01/2007 - "ATP has had less efficacy for faster VTs (41-79%) and have higher probability of accelerating tachycardia (5-55%). " 04/01/1990 - "Intravenous adenosine triphosphate during wide QRS complex tachycardia: safety, therapeutic efficacy, and diagnostic utility." 11/01/1989 - "We conclude that adenosine triphosphate is a useful, safe and effective drug at low dose in correctly diagnosed reentrant tachycardias involving the atrioventricular node. " 11/01/1989 - "Intravenous adenosine triphosphate has been proved to be useful for the treatment of supraventricular tachyarrhythmias. " Order ALL the reference details at left...

Therapies and Procedures

1.	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 01/01/2006 - "RECENT FINDINGS: A number of important randomized clinical trials on the efficacy of prophylactic implantable cardioverter defibrillator therapy in patients deemed to be at high risk for ventricular tachyarrhythmias have recently reported their results. " 10/01/1997 - "The implantable cardioverter-defibrillator (ICD) is an implantable electronic device that has been proven to be safe and effective in treating various malignant tachyarrhythmias in susceptible individuals. " 04/07/2001 - "Implantable cardioverter defibrillators (ICDs) have evolved from the treatment of last resort to the gold standard therapy for patients at high risk for ventricular tachyarrhythmias. " 10/01/1997 - "OBJECTIVE: To determine whether implantable cardioverter-defibrillator (ICD) treatment is beneficial in elderly patients with life threatening ventricular tachyarrhythmias. " 01/01/2007 - "BACKGROUND: The implantable cardioverter-defibrillator (ICD) is the mainstay of treatment for ventricular tachyarrhythmias due to its impact on mortality. " Order ALL the reference details at left...
2.	Defibrillators (Defibrillator) 09/01/2002 - "CONCLUSIONS: Atrial antitachy pacing and shock therapies demonstrated very high efficacy in treating atrial tachyarrhythmias in defibrillator patients." 05/01/2006 - "Ventricular tachyarrhythmia induction by strong cardiac shocks: can understanding underlying mechanisms lead to improved prevention of defibrillator failure?" 08/01/1985 - "The available data indicate that the automatic cardioverter-defibrillator can reliably identify and correct potentially lethal ventricular tachyarrhythmias, leading to a substantial improvement in survival in properly selected high risk patients." 07/01/2007 - "The Multicenter UnSustained Tachycardia Trial (MUSTT) investigated whether electrophysiologic study (EPS) was helpful in choosing drug or defibrillator therapy in patients induced into sustained VT. " 01/01/1993 - "Our experience shows that the transvenous Medtronic Pacer Cardioverter Defibrillator System provides safe, effective treatment of ventricular tachyarrhythmias. " Order ALL the reference details at left...
3.	Electric Countershock (Cardioversion) 01/20/1993 - "11 out of 17 patients (65%) experienced one or more episodes of tachyarrhythmias which was treated successfully with overdrive pacing (ramp or burst), cardioversion or defibrillation. " 02/01/1978 - "In a large number of cases, electrotherapeutical approaches such as DC-cardioversion and cardiac pacing are effective in controlling ectopic tachycardias. " 11/01/1993 - "A tachycardia-related efficacy of 69% and patient-related efficacy of 46% of the low-energy cardioversion < or = 4 joules was observed. " 09/01/2006 - "Serum cardiac markers response to biphasic and monophasic electrical cardioversion for supraventricular tachyarrhythmia--a randomised study." 11/01/2003 - "The study population consisted of 22 patients who developed supraventricular tachyarrhythmias after transthoracic cardioversion (300 J) delivered to stop a VT or VF induced by electrophysiological study. " Order ALL the reference details at left...
4.	Drug Therapy (Chemotherapy) 12/01/2005 - "Drug therapy is only slightly effective, and the best treatment is ablation of the right branch of the bundle of His, which stops the tachycardia definitively." 09/01/2002 - "CONCLUSION: Radiofrequency ablation is a safe and effective treatment for AP mediated tachycardia, especially for younger patients and children in whom life-long drug therapy may not be best option." 08/01/2004 - "1. Self-awareness frequency of tachycardia attack, frequency of going to hospital and life CONCLUSION: limitations of PSVT patients decreased after CA. 2. QOL (social and physical QOL) and mental health condition significantly improved after CA. 3. Almost all patients (98.3%) gave a positive evaluation of CA. 4. Healthcare professionals should be aware that not only drug therapy, but also CA is effective for improvement of mental health and the QOL of patients with PSVT." 02/01/1999 - "Considering the number of at-risk patients, it is likely that drug therapy will remain the mainstay of treatment of patients with ventricular tachyarrhythmias. " 01/01/2003 - "The influence of concomitant drug therapy on the efficacy of atrial overdrive stimulation for prevention of atrial tachyarrhythmias." Order ALL the reference details at left...
5.	Cryosurgery 05/01/2009 - "AIMS: The purpose of this study was to evaluate the safety and efficacy of cryoablation as an alternative to radio frequency (RF) ablation in high-risk-located atrial tachycardia (AT). " 11/01/2005 - "Cryoablation at a mid-septal location under three-dimensional guidance successfully eliminated both tachycardias without detrimental effects to the AV node." 03/01/1985 - "The single exception at the present time is surgery for AV node reentry tachycardia, which appears to be easily cured by the new technique of discrete cryosurgery of the peri-AV nodal region of the lower right atrial septum. " 12/01/2006 - "AIMS: The efficacy of transvenous Cryoablation (Cryo), for the treatment of atrioventricular nodal re-entry tachycardia (AVNRT), when compared with radiofrequency (RF) ablation, requires further investigation. " 04/05/2005 - "OBJECTIVES: We investigated the safety and efficacy of cryoablation in the treatment of pediatric patients with accessory pathways (APs) located near the atrioventricular junction and with atrioventricular nodal re-entrant tachycardia (AVNRT). " Order ALL the reference details at left...

Best Treatments:
Research Summary Report
on Tachycardia

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 639 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>